Article

Gene Therapy – What’s Next? One of the most talked about topics in medicine at the moment is gene therapy. Seroba Partner, Bruno Montanari, watches the field closely and talks here about the current state of play, the challenges and the opportunities. Gene therapy is an exciting area of medicine still in its emerging phase […]

In this video, Steve Levin of Medtech Strategist and Market Pathways, describes the medtech reimbursement system in Germany, focusing in particular on the NUB program.

Webinar – Seroba’s Jennifer McMahon is joined by Georgina Murphy of the Ireland Strategic Investment Fund and Kathy Kelly of Atlantic Bridge for a wide-ranging discussion on gender diversity in our industry.

Unmasking The IPO Market Pandemic panic shut the IPO window with a bang in March.  Amazingly though, not only did the window open again in April, but it eventually took off like a rocket. The result, a record year for biotech companies raising funds through an IPO. By 30 September, 87 IPOs had raised over

The Most Important Sector In The World This has been no less of an extraordinary period for the life sciences industry than it has been for each of us personally. The pandemic has created huge problems, including clinical trial delays, limited access to hospitals or clinicians and disruption to supply lines. Despite the challenges, the

A Precision Exit Seroba was pleased to see its portfolio company, PrecisionBiotics, acquired by Novozymes in June 2020. The company, originally known as Alimentary Health, was a global pioneer in the study of the human microbiome and of the application of that knowledge to improvements in human health. Partnering with the world-leading APC Microbiome Centre

Lecture at the Royal Irish Academy in September 2019 by Prof. Thomas Cech. Professor Thomas Cech, Nobel Laureate. In September 2019, the Royal Irish Academy on Dawson Street in Dublin hosted a lecture by Nobel Laureate, Prof. Tom Cech. This impressive Professor from the University of Colorado, Boulder, is Scientific Advisor to Seroba’s portfolio company,

The Big Taboo Seroba’s investment in Atlantic Therapeutics has helped fund additional clinical trials of INNOVO®, a pair of really smart shorts that delivers muscle stimulations to strengthen the pelvic floor. The positive results of those trials are now being used to support the new advertising for INNOVO®, which aired on UK and French TV channels

Let’s Talk Exits Seroba Partner, Daniel O’Mahony, talks about being a VC and about investing in life. What’s the most exciting part of your role as a VC – Is it all about exits? I think venture capital is one of the most exciting jobs in the world. On a daily basis I get to

Alimentary Health If you’ve noticed that your friends or colleagues seem pretty chilled out lately, perhaps it’s because they’ve been sampling Zenflore®, a ground-breaking new product recently launched by Alimentary Health. Seroba’s portfolio company, Alimentary Health, based in Cork in Ireland is a global pioneer in the discovery, development and commercialisation of proprietary microbiome-based and